MICHAEL KA KEUWONGMICHAEL KA KEU WONG12739WONG, MICHAEL KA KEUProfessorFaculty Rankprns:fullNamefull nameprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:minWeightminimum weightprns:numberOfConnectionsnumber of connectionsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:sortOrdersort orderAcademic ArticleArticleDocumentAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsAuthorshipDepartmentDivisionvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonMelanoma Medical OncologyMD Anderson74Professor1400 Holcombe BlvdHouston77030-4008TX1114selected publicationsAuthorship 841789Authorship 842508Authorship 843370Authorship 843387Authorship 844595Authorship 845207Authorship 847694Authorship 853461Authorship 854417Authorship 854785Authorship 855333Authorship 857472Authorship 864447Authorship 866972Methods for Monitoring of the Anti-Angiogenic Activity of Agents in Patients. 341-359.Methods for Monitoring of the Anti-Angiogenic Activity of Agents in PatientsCommunity OncologyMelanoma biology. Community Oncology. 5:6-13.Melanoma biologyAmerican Journal of Clinical Oncology: Cancer Clinical TrialsErratum. American Journal of Clinical Oncology: Cancer Clinical Trials. 28:455.ErratumCancer ResearchErratum. Cancer Research. 61:5956.ErratumONCOLOGY (United States)Weighing the evidence for immune therapy and targeted therapy in renal cancer and melanoma. ONCOLOGY (United States). 27.Weighing the evidence for immune therapy and targeted therapy in renal cancer and melanomaUnknown JournalUltrasound contrast microbubbles targeted to tumor angiogenesis specifically bind tumor-derived endothelial cells. Unknown Journal. 2:897-898.Ultrasound contrast microbubbles targeted to tumor angiogenesis specifically bind tumor-derived endothelial cellsInvestigating a new entubulation strategy to overcome peripheral nerve injury. 751-752.Investigating a new entubulation strategy to overcome peripheral nerve injuryCancer Immunology, ImmunotherapyContemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma. Cancer Immunology, Immunotherapy. 1-12.Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinomaAmerican Health and Drug BenefitsReview of US comparative economic evidence for treatment of metastatic renal cell carcinoma after failure of first-line VEGF inhibitor therapy. American Health and Drug Benefits. 6.Review of US comparative economic evidence for treatment of metastatic renal cell carcinoma after failure of first-line VEGF inhibitor therapyCurrent OncologyThe role of tissue culture in oncology research. Current Oncology. 5:67-69.The role of tissue culture in oncology researchCurrent OncologyThe genetic study of cells. Current Oncology. 5:4-8.The genetic study of cellsClinical Genitourinary CancerImpact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy. Clinical Genitourinary Cancer. Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 ImmunotherapyJournal for ImmunoTherapy of CancerImplementation of an Interleukin-2 National Registry. Journal for ImmunoTherapy of Cancer. 2.Implementation of an Interleukin-2 National RegistryCancer ResearchErratum. Cancer Research. 61:4297.Erratumtrue1ProfessorProfessor